NATALIA BRIGHAM: Open Payments
NPI 1992209993 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 10 payments from 7 companies in 2025. Trend: 2023 $61 · 2024 $369 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 1 | $114 |
| Otsuka America Pharmaceutical, Inc. | 4 | $92 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Corium, LLC | 1 | $8 |
Products named: LYBALVI, REXULTI, Auvelity, INGREZZA, VRAYLAR, TRINTELLIX, Azstarys.
Industry payments across VA — which companies pay providers there.
